Sign in

CIK 0001844417 · <br>Emerging growth company

Estrella Immunopharma, Inc.

Sign in to watch
Ticker
ESLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
861314502
Phone
(510) 318-9098
Business address
5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Former names
TradeUP Acquisition Corp.

Securities

  • ESLA Common Stock Nasdaq
  • ESLAW Warrant Nasdaq
  1. 10-Q Report Quarterly Report
  2. 424B3 Offering Prospectus
  3. 8-K Event Auditor change
  4. 8-K Event Other events
  5. EFFECT Other Notice of Effectiveness
  6. 424B3 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. S-1/A Offering Registration Statement
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. UPLOAD Other SEC-generated Letter
  11. 10-Q Report Quarterly Report
  12. NT 10-Q Other NT 10-Q
  13. 8-K/A Event Bylaws or fiscal year change
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. S-1/A Offering Registration Statement
  16. SC 13D Stake Beneficial Ownership Report
  17. UPLOAD Other SEC-generated Letter
  18. S-1 Offering Registration Statement
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 5 of 13 · 258 filings